In the BioHarmony Drug Report Database
Reserpine
Hiserpia, Rau-sed, Reserpine, Sandril, Serpalan, Serpanray, Serpasil, Serpate, Serpivite (reserpine) is a small molecule pharmaceutical. Reserpine was first approved as Hiserpia on 1982-01-01. It is used to treat dyskinesias, hypertension, and schizophrenia in the USA. The pharmaceutical is active against synaptic vesicular amine transporter. In addition, it is known to target chromaffin granule amine transporter.
Trade Name
|
Hiserpia, Rau-sed, Reserpine, Sandril, Serpalan, Serpanray, Serpasil, Serpate, Serpivite |
|---|---|
Common Name
|
reserpine |
ChEMBL ID
|
CHEMBL772 |
Indication
|
dyskinesias, hypertension, schizophrenia |
Drug Class
|
Tricyclic compounds; Rauwolfia alkaloid derivatives |
Image (chem structure or protein)